|
|
Home | Alpha Telephone | Domain Names | Web Hosting | Get Traffic | xrEvidence | xrSoccer United States Patent
ELECTROSTATIC TREATMENT APPARATUS WITH CHARGE DISPERAL MEANS A medical treatment apparatus which improves upon existing high negative potential therapeutic devices by providing a single conductor member coupled to the single electrode which in turn is electrically connected to the generating means for generating the high negative potential charge. The single electrode has a continuous charge of only one type of magnetic polarity extending perpendicular from one surface of the electrode adapted to be placed over a subject to be treated. The magnetic field lines which extend perpendicularly from the treatment surface will extend perpendicularly into the surface of the patient being treated and the high negative potential charge deposited upon the surface of the patient will be dispersed along the surface of the patient substantially in a perpendicular direction to the magnetic field lines.
What we claim is: 1. In a medical treatment apparatus comprising means for generating a high negative potential charge and a single electrode electrically connected to said generating means for transmitting the high negative potential charge, the improvement comprising a single conductor member coupled to said single electrode and having a treatment surface adapted to be placed over a subject to be treated, said treatment surface having a continuous charge of only one type of magnetic polarity causing magnetic field lines extending perpendicularly from said treatment surface, whereby the high negative potential charge will be dispersed along the surface of the subject to be treated. 2. The apparatus as in claim 1, wherein said single conductor member has a surface opposite said treatment surface having a continuous charge of magnetic polarity thereon whose polarity type is opposite to that of the polarity on the treatment surface. 3. The apparatus as in claim 1, wherein said single electrode is in the form of a probe and said single conductor member is a circular disk electrically coupled to said probe. 4. An apparatus as in claim 1, and further including conductive means spaced apart from said single conductor member and having a first surface facing said treatment surface, said first surface having a continuous charge of only one type of magnetic polarity whose type is opposite to the polarity type on said treatment surface. 5. An apparatus as in claim 4, wherein said conductive means is a magnetic slab. 6. A medical treatment apparatus comprising means for generating a high negative potential charge, a single electrode electrically connected to said generating means for applying the high negative potential charge and a single conductor member coupled to said single electrode having a treatment surface, said surface having a continuous charge of only one type of magnetic polarity causing magnetic field lines extending perpendicularly from said treatment surface, whereby the high negative potential charge will be dispersed along the surface of the subject to be treated. 7. The apparatus as in claim 6 wherein said conductor member has an opposite surface having a continuous charge of an opposite magnetic polarity. BACKGROUND OF THE INVENTION This invention relates to a high negative potential charge therapeutic device and more particularly to an improvement upon such existing high negative potential charge therapeutic devices by including means for dispersing the high negative charge particles accumulated on the surface of the patient being treated. A high negative potential charge therapeutic device which is known in the art differs from conventional electric therapeutic devices. In the conventional electric therapeutic devices two conductors are connected to different points on the patient being treated and a current flows between the two conductors making the patient a part of the conductive circuit between the two conductors. In a high negative potential charging therapeutic device only a single electrode is used which deposits the negative charge on the surface of the patient being treated. When the high negative potential charge contacts the surface of the patient being treated, negative ions are increased in the serum of the patient in proportion to the potential applied. This results in a change in the membrane potential of the cell membrane; the metabolism of nutrition is accelerated; the activity of the enzyme in the protoplasm is increased, and a series of other biochemical reactions are carried out. These were reported by Mr. M. Takada (Potential Therapy, 1940). Since the human body is different from an ordinary electrolytic cell, battery or metal conductor, the high negative potential charge applied to the surface of the body during treatment cannot easily be dispersed along the surface of the body from the immediate contact portion within a short period of time. As a result, the high negative potential charge accumulates in a localized area where it is initially applied and remains concentrated in that localized area. This concentration in a localized area on the surface of the body brings about cathodal electric tension to the body. It is therefore an object of the present invention to overcome the concentrated and localized tendency of the high negative potential charge in a high negative potential charging therapeutic device. A further object of the present invention is to provide counter measures to the tendency of the high negative potential charge concentrating in a localized area when a high negative potential charging therapeutic device is used and at the same time effectively preserve the original effect of the high negative potential charging therapeutic device as much as possible. Still a further object of the invention is to provide means for quickly dispersing the high negative charge along the surface of the patient to be treated thereby diluting the effect of local concentration of high negative potential and reducing the electric tension resulting therefrom. BRIEF SUMMARY OF THE INVENTION In a high negative potential charging therapuetic device there is generally a generator for providing the high negative potential charge and a single electrode which serves as a probe electrically connected to the generating means for transmitting the high negative potential charge onto the patient. The present invention couples a single conductor member to the single electrode. The single conductor member has a treatment surface which is adapted to be placed over the subject to be treated. The treatment surface has a continuous charge of only one type of magnetic polarity which causes magnetic field lines to extend perpendicularly from the treatment surface. As is well known in the art, the electric field will be perpendicular to the magnetic field. As a result, as the magnetic field lines reach the patient being treated they are substantially perpendicular to the surface of the patient and effectively penetrate the surface body of the patient. As a result, the electric field lines being perpendicular to these magnetic field lines will cause the high negative potential charge on the surface of the patient being treated to be dispersed along the surface of the patient thereby effectively eliminating the electric tension resulting from the concentration and localization of the high negative potential charge. A fuller understanding of the nature and features of the invention will be had from the following description taken in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE FIGURES FIG. 1 is a pictorial view showing an embodiment of the therapeutic device of the present invention; FIG. 2 is a top view of a portion of FIG. 1 showing an embodiment of the single conductor member thereof; FIG. 3 is a cross sectional view taken along line A--A of FIG. 2; FIG. 4 is a side view of the single conductor member showing the magnetic field lines extending perpendicular from the conductor member, and FIG. 5 is a pictorial view of another embodiment to the present invention. Referring now to FIGS. 1-4 there is shown a high negative potential charging device referred to generally by numeral 1. This device, as is well known in the art includes generating means for generating the high negative potential charge. A single electrode 3 is electrically connected to the device 1 which serves as a probe for transmitting the high negative potential charge onto a patient being treated. In accordance with this invention, a single conductor member 2 is coupled to the single electrode. The single conductor member has a treatment surface shown in the figures as the bottom surface which is adapted to be placed over a subject to be treated. The treatment surface of the single conductor member has a continuous charge of only one type of magnetic polarity, either a N or S which causes magnetic field lines to extend perpendicularly from the treatment surface, as is shown by the dotted lines in FIG. 4. In a magnetic field, the charge particles get closer to and then away from a north pole or a south pole while forming eddy type magnetic lines of force within the bipolar magnetic field. Namely, the charged particles reciprocate between the N pole and the S pole and at the same time the charge particles slowly move around the N and S axes of the magnetic field, and are distributed in the form of a doughnut around the central magnet as is generally known. Therefore, when either of the poles N or S of the bipolar magnetic field is placed continuously on the treatment surface of the single conductor member and when the opposite pole is caused to exist on the other surface of the single conductor member a magnetic field will be produced wherein the field lines will be as shown in FIG. 4. When the magnetic field lines which are perpendicular from the treatment surface of the single conductor member, are applied onto the patient to be treated they extend perpendicularly into the patient being treated. The electric field lines, which are perpendicular to the magnetic field lines, will therefore pass along the surface of the patient being treated. These electric field lines will reduce the concentration and localization tendency of the high negative potential charge on the surface of the patient being treated by dispersing the charge along the surface of the patient. Generally speaking, the speed of the dispersion is controlled by the movement of non-pair electrons in the transitional state when free radicals or ion particles are added or the degree of the non-localization thereof. However, such a change is remarkably increased in a magnet field and therefore the dispersion of the concentrated and localized high negative potential is brought about quickly. At the same time, as is generally known to those skilled in the art, there may also be electromagnetic induction between the magnet field and the circulation system of the body being treated and specifically by the flowing blood and structural liquid in that body. The starting power (E) represented by the following general formula is induced and the probability of ionization of the interstructural molecules is increased, and therefore it is desirable that a preferable environment be provided for the dispersion of the charged particles of the local portion where negative potential is contacted. The present invention is characterized in that the effect of the high negative potential charge can be sufficiently provided while presenting or relaxing the abnormal tension in the various kinds of somatological reactions resulting from the concentration and localization of the high negative potential charge. This results from the dispersion along the surface of the body of the high negative potential charge. The general formula for E is as follows: E= uH.sub.1v .times. 10.sup..sup.-8.sup.' In the above given general formula, E is the starting power in volts, u is the permeability of blood, H is the strength of the magnetic field in oersteds, l is the cross sectional area of blood vessels in square centimeters, and v is the velocity of the blood flow in centimeter seconds to the -1 power. The formation of the one type of magnetic polarity on the treatment surface of the single conductor member can be provided by using a permanent magnet, a solenoid, or an electromagnet. In the case of the latter two it is preferable to use Direct Current electricity although it might also be possible to use AC electricity. In the embodiment shown in FIG. 4. the surface opposite that of the treatment surface of the single conductor member has a continuous magnetic charge opposite that of the treatment surface whereby the magnetic field lines extending perpendicularly from the treatment surface close onto the opposite surface of the single conductor member. Referring now to FIG. 5, there is shown another embodiment of the present invention. In FIG. 5, like parts of the device are identified by like numerals as in the previous drawings. As is shown, in addition to the single conductor member 2 coupled to the single electrode 3 and having a treatment surface facing the patient 4 having a continuous charge of N magnetic field, there is also provided an additional magnet 5 placed in such a manner to locate the patient being treated between the magnet 5 and the single conductor member 2. The magnet 5 has a surface facing the patient to be treated whose magnet field is opposite to that of the magnetic field on the treatment surface of the single conductor member 2. In the embodiment as shown in FIG. 5 the surface of magnet 5 facing the patient will have an S field. As a result, the magnetic field lines extending perpendicularly from the treatment surface of the single conductor member 2 will travel substantially perpendicularly and close onto the surface S of the magnet 5. The electric field lines, being substantially perpendicular to the magnetic field lines will therefore be parallel to the surface of the patient being treated. These will disperse the high negative potential charge deposited onto the treatment surface of the patient by the high negative potential charging therapeutic device. According to the report of Mr. Gomi, Iijima (No. 6756) entitled "Effect of static potential on normal mice" in Medicine and Biology, No. 79, No. 3 (Sept. 10, 1969): 1. The charge of high negative potential on an organism increases the magnetism intensity of the lymph gland extraction and at the same time increases the stability and activation of the heterogenetic protective function of the lymph system beyond the normal immunity to say nothing of antiulcer characteristics. 2. The magnetic field effect increases the activity of the muscles, heart nerves and acetylcholine. 3. The magnetic field interferences given by the high negative potential charge together with the magnetic force do not show any recognizable harmful effects but the magnetic field interferences effectively increases the function of the lymph system and adjusts the functions of the nerve system as apparent from the measurement of magnetism intensity. The clinical effects of the present invention were examined by combining the magnetic effect of the magnetic field lines along with the heterogenetic and general high negative potential charge. Magnetic material whose average coercive force was 500 gauss was placed onto the single electrode extending from the DC type high negative potential therapeutic charging device (produced by Matsushita Electric Works Co., Ltd.). The terminal with the magnetic material connected to it was placed over the patient at the occipital portion closest to the hypothalamus and the peripheral system (diencephalon) and high negative potential charge and magnetic field effect were simultaneously given to patients for 15 minutes/day/person. The multiplying effects of the high negative potential charge and the magnetic field were clinically applied and as a result the following conclusions were arrived at: 1. No harmful factors worthwhile to draw specific attention could be recognized inclusive to physical toxicity. 2. At least more than 70 percent of the symptoms such as head-ache, shoulder discomfort, neuralgia, constipation, insomnia or such like diencephalic syndrome were treated and no harm could be observed. Immediate effect could be recognized. 3. As the tests showed the terminal with the magnetic material having the magnetic field lines perpendicular thereof could be used as a treatment device. The preferable magnetic coercive force of the magnetic circuit provided on the negative potential generating portion is from 350 to 400 gauss, but it is not restricted to the above mentioned range of coercive force. On the other hand, in regard to the negative potential to be charged, it can be above 300V, or it can be minute voltage. In regard to the potential generators, those conventional potential generators which are not being commercially distributed on market can be used. Also, such potential generators wherein a nucleous capable of radiating only .beta.-ray weakly by 100 percent, and radiating no .alpha.-ray or .gamma.-ray is wrapped in metallic magnet alunico, vicalloy, permalloy, N-type semiconductor, or a negative charge high polymer in such a manner that radiation cannot leak out. The thickness of said wrapping material is generally several millimeters to prevent .beta.-ray, and there is no fear that a health drawback should occur. The potential generator of the above mentioned type is preferable as the product of the present invention provided with conductor. Some of the nuclear material which is generally used in such generators, together with their output characteristics are given in the table below: Nuclear Half-period (year) Energy Material (Mev) C - 14 5570 0.156 Si - 32 700 0.10 Ni - 63 120 0.067 Se - 79 6.5 .times. 10.sup.4 0.160 Ro - 87 4.7 .times. 10.sup.10 0.273 Sr - 90 28 0.544 Zr - 93 9.5 .times. 10.sup.5 0.063 Tc - 99 2.1 .times. 10.sup.4 0.292 Pb - 107 7 .times. 10.sup.6 0.035 In - 115 6 .times. 10.sup.14 0.50 Cs - 135 2.0 .times. 10.sup.6 0.210 Re - 187 6 .times. 10.sup.10 0.008 There has heretofore been described the best embodiments of the invention presently contemplated and it is understood that various changes and modifications may be made by those skilled in the art without departing from the spirit of the invention. For U.S. patent law, rules, and procedures see MPEP. Disclaimer. Information presented on this page while believed to be reliable, is provided "as is" with no warranties of its accuracy or timeliness. For legal advice seek help of a licensed professional. |